An overview of the most important medicinal plants affecting cardiac arrhythmia in Iran by Cheraghi, Mostafa. & Asadi-Samani, Majid.
www.scholarsresearchlibrary.comt Available online a 
 
 
 
 
 
 
Scholars Research Library 
 
Der Pharmacia Lettre,  2016, 8 (5):87-93 
(http://scholarsresearchlibrary.com/archive.html) 
 
 
ISSN 0975-5071 
USA CODEN: DPLEB4 
 
87 
Scholar Research Library 
An overview of the most important medicinal plants affecting cardiac 
arrhythmia in Iran 
 
Mostafa Cheraghi1 and Majid Asadi-Samani2* 
 
1Madani Heart Hospital, Lorestan University of Medical Sciences, Khorramabad, Iran 
2Student Research Committee, Medical Plants Research Center, Shahrekord University of Medical Sciences, 
Shahrekord, Iran 
_____________________________________________________________________________________________ 
 
ABSTRACT 
 
Oxidative stress occur in several diseases such as cardiovascular disease, diabetes, cancer, aging and Alzheimer's 
disease. Cardiac arrhythmia is today a common clinical problem presenting with decrease, increase or mismatch in 
normal heart rhythm that cause reduction in cardiac output. Given the importance of heart diseases and noting that 
in many countries, cardiovascular diseases are among the top causes of death and the leading cause of disability 
and the fact that application of medicinal plants and herbal medicines is common in the treatment of hypertension, 
ischemic heart disease, congestive heart disease, arrhythmias and angina pectoralis, therefore, this review aimed to 
identify the anti-arrhythmic medicinal plants indigenous in Iran. Due to the proven anti-arrhythmic effects of 
medicinal herbs including grape, sour orange, olive, pokeweeds and nettle and regarding the obvious phytochemical 
agents in them, so hesperidin, naringin, deosepyn, apigenin, aloroporin and hydroxytyrosol, phytolactosin, 
catechins, betacianin, tannins and free phenolic acids can be used as anti-arrhythmic ingredients used for the 
production of bioactive agents. 
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INTRODUCTION 
 
Oxidative stress occur in several diseases such as cardiovascular disease, diabetes, cancer, aging and Alzheimer's 
disease. Today, cardiac arrhythmia is a common clinical problem and is observed in 25% of patients treated with 
digitalis, 50% of patients under anesthesia and more than 80% of patients with acute myocardial infarction. 
Arrhythmias in form of decrease or increase in normal heart rhythm or rhythm mismatch decrease the cardiac output 
[1-5]. Some of these arrhythmias are very serious and can be fatal, if not controlled [6]. There are several types of 
arrhythmia [7]. Atrial fibrillation increases the risk of stroke and congestive heart failure, and mortality due to 
coronary artery disease [8]. Atrial and ventricular arrhythmias are the most common complications after surgery. 
Occurrence of arrhythmia, especially coronary artery fibrillation (CABG), as the most common disease, although 
does not increase the risk of mortality of AF patients, increases the length of stay in special care unit [9, 10]. Given 
the importance of heart diseases, it’s notable that in many countries, cardiovascular diseases are among the top 
causes of death and a major cause of disability [11]. 
 
Medicinal plants are one of the most popular treatments in complementary medicine [12-27]. The use of medicinal 
plants were traditionally common in Iran [28-43]. These compounds have a natural origin [44-59] and have fewer 
side effects than chemical drugs [60-73]. In recent decades, people’s tendency towards these drugs have increased 
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[74-85]. Biologic combinations with herbal origin are considered an important branch of drug treatment [86-96]. In 
many cases, medications with plant origin are less expensive and are associated with fewer side effects than 
chemical drugs [97-106]. Treatment with medicinal plants and herbal medicines are common in patients with 
hypertension, ischemic heart disease, congestive heart disease, arrhythmias and angina pectoralis [107]. Thus, the 
current review aimed to identify the anti-arrhythmic medicinal plants indigenous in Iran. 
 
The information of the current review was obtained by searching keywords “cardiovascular diseases, arrhythmia, 
medicinal plant, extracts and essence” from scientific articles published in databases such as SID, Scopus, PubMed, 
Magiran, Google scholar and etc. 
 
Iran's scientific literature review showed that 5 herbs (grape, sour orange, olive, pokeweeds and nettle) are used for 
the treatment of cardiac arrhythmias. Additional information affecting the plants are listed in Table 1. 
 
Table 1. Antiarrhythmic medicinal plants in Iran 
 
Explanation English 
name 
Family name Scientific 
name 
No. 
Hydro-alcoholic perfusion of grape seed extract reduces the infarct size from 31%±5 to 
12%±3, 16%±6 and 2%±1, respectively, for extract concentrations of 1, 10 and 100. 
Perfusion of concentration of 1 µg/L of the extract reduces the number, duration and 
incidence of ischemic VT phase. So hydro-alcoholic perfusion of grape seed extract was 
proven effective in arrhythmia caused by ischemia-reperfusion in rat’s heart in terms of 
reducing infarct size and arrhythmias [107]. 
Grape Vitaceae Vitis vinifera 1 
Hydro-alcoholic extract of sour orange has a biphasic dose-dependent pattern, as in low 
and medium concentrations (0.8 and 3.2 mg/mL), it reduces nodal and wenkebach 
refraction. Also, sour orange extract non-significantly reduces the average distance 
between two consecutive records of the his bundle and the amount of hidden beats in all 
concentration extract. This mechanism possibly acts through stimulation reduction and 
regional node refraction and hidden areas and partly through the beta-mediated 
receptors [108]. 
Sour 
orange Rutaceae 
Citrus 
bigaradia 2 
The gavage of 200 mg/kg  of olive for 1, 3, 7, 14 and 28 days significantly decreased the 
severity of arrhythmias, including the number of premature ventricular beats (VEBs), 
incidence of ventricular tachycardia (VT) and ventricular fibrillation (VF) in the groups 
that received at least 14 days extract. Also, VT and VF frequency and time showed 
significant differences in groups of 14 and 28 days; ultimately, olive leaf extract help 
protect the heart [109]. 
Olive Oleaceae 
 
Olea 
europaea L 3 
The results of a study showed that extracts of phytolacca can be used to measure the 
kinetics of recovery atrioventricular node. Also it  showed dose-dependent effect of the 
herb extract with effect on basic and functional index of the atrioventricular node in 
heart of rats and caused partial VWCL, AVCT depression and is effective on AV node 
refractory period. So, this plant has anti-arrhythmia supraventricular role [110]. 
Pokeweeds Phytolaccaceae Phytolacca decandra L. 4 
Results of a study showed that a concentration of 1 g/L of ethanol extract of nettle 
significantly depresses the basic and functional properties of atrioventricular node, as it 
had a significant increase in Wenkebach indices and functional refractory period and 
nodal conduction time that shows anti-arrhythmic activity of hydro-alcoholic extract of 
nettle that is probably effective through the mechanism of  energy-dependent 
communication with sodium-potassium pump inhibition and supraventricular treatment 
[111]. 
Nettle Urticaceae 
 
Urtica 
dioica L. 5 
 
DISCUSSION 
 
Cardiac arrhythmia is a common clinical problem today. Based on the obtained results, medicinal herbs including 
grape, sour orange, olive, pokeweeds and nettle herbs are used in the treatment of cardiac arrhythmias. 
 
In traditional medicine, sour orange plant was used to treat headaches, chest pain, skin freshness, and as sedatives 
and tonics [112, 113]. The most important flavonoids of sour orange include hesperidin, naringin, deosepin, and 
apigenin [114]. Olive leaf was the traditional treatment for fever, malaria, hypertension, gout, diabetes and 
atherosclerosis [115, 116]. Olive is a rich source for polyphenols, especially oleoropin and its derivatives such as 
hydroxytyrosol [117-121]. Phytolacca was used in traditional medicine to treat rheumatism, ascorbate, 
dysmenorrhea, and constipation. It has been clarified that specified parts of phytolacca plant contain substances such 
as Fitolactocin, catechins, betacianin, tannins and free phenolic acids [122]. 
 
Majid Asadi-Samani et al Der Pharmacia Lettre, 2016, 8 (5):87-93 
______________________________________________________________________________ 
89 
Scholar Research Library 
Regarding the antiarrhythmic effects of medicinal herbs including grape, sour orange, olive, pokeweeds and nettle, 
proven by clinical researches and considering their phytochemicals, hesperidin, Naringin, deosepin, apigenin, 
oleoropin, hydroxytyrosol, Fitolactocin, catechins, betacianin, tannins and free phenolic acids can be used as anti-
arrhythmic active ingredients, used for the production of bioactive agents. Oxidative stress induces molecular 
oxidative damage, which in turn cause cellular dysfunction and impairment of organ function thus they involve in 
the pathogenesis of diseases [123-126]. Cardiac arrhythmia is associated with increase in free radicals and oxidative 
stress [127]. Medicinal plants introduced here mostly have antioxidant activities. Which may acted, at least in part, 
by this way. There are a lot of other medicinal plants which have antioxidant properties [128-180]. These herbs may 
also have anti-arrhythmic activities which worth examining. 
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